GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioTech Medics Inc (OTCPK:BMCS) » Definitions » COGS-to-Revenue

BioTech Medics (BioTech Medics) COGS-to-Revenue : 0.00 (As of . 20)


View and export this data going back to . Start your Free Trial

What is BioTech Medics COGS-to-Revenue?

BioTech Medics's Cost of Goods Sold for the three months ended in . 20 was $0.00 Mil. Its Revenue for the three months ended in . 20 was $0.00 Mil.

BioTech Medics's COGS to Revenue for the three months ended in . 20 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. BioTech Medics's Gross Margin % for the three months ended in . 20 was N/A%.

BioTech Medics COGS-to-Revenue Historical Data

The historical data trend for BioTech Medics's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioTech Medics COGS-to-Revenue Chart

BioTech Medics Annual Data
Trend
COGS-to-Revenue

BioTech Medics Quarterly Data
COGS-to-Revenue

BioTech Medics COGS-to-Revenue Calculation

BioTech Medics's COGS to Revenue for the fiscal year that ended in . 20 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
= /
=

BioTech Medics's COGS to Revenue for the quarter that ended in . 20 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
= /
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioTech Medics  (OTCPK:BMCS) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

BioTech Medics's Gross Margin % for the three months ended in . 20 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - /
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

BioTech Medics COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of BioTech Medics's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

BioTech Medics (BioTech Medics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioTech Medics Inc (OTCPK:BMCS) » Definitions » COGS-to-Revenue
Comparable Companies
NUVPF ADMD RSPI YBAO ULUR NRXCF ACUR LBLTF PUFXF BKIT RLMD IGC MYOS CBICF SBFM PVCT AQSZF PTLF AOLS APRI
Traded in Other Exchanges
N/A
Address
5850 Canoga Avenue, Suite 400, Woodland Hills, Los Angeles, CA, USA, 91367
Website
http://www.biotecmedics.com
BioTech Medics Inc is a medical-based holding company. The company operates through four divisions namely Medical, Nutraceutical Products, Sports Medicine, and Research and Development.